期刊文献+

TUSC3基因在胰腺癌组织中的表达 被引量:1

TUSC3 GENE EXPRESSION IN PANCREATIC ADENOCARCINOMA DETECTED BY OLIGONUCLEOTIDE MICROARRAY
暂未订购
导出
摘要 目的研究TUSC3基因在正常胰腺和胰腺癌组织中的表达水平。方法利用寡核苷酸基因芯片技术和实时定量PCR技术检测20例胰腺癌组织和6例正常胰腺组织中TUSC3基因的表达。芯片杂交结果进行Ratio值分析,实时定量PCR进一步验证杂交结果,PCR产物的定量方法采用比较Ct法。结果芯片扫描图像信号清晰,具有较低的整体背景和较高的信噪比。与正常胰腺组织相比,TUSC3基因在胰腺癌组织中表达下调,平均Ratio值为0.297±0.38。荧光定量PCR结果:TUSC3基因平均模板量在正常胰腺组织中为0.0387493±0.00965,胰腺癌组织中为0.0206028±0.00401;与正常胰腺组织相比,胰腺癌组织中TUSC3基因表达下调1.88倍(P<0.05)。结论TUSC3基因在胰腺癌组织中表达水平明显下调,其可能机制与该基因启动子区过甲基化有关,TUSC3基因在胰腺癌发生发展中的生物学效应值得进一步研究。 Objective To investigate the expression of the TUSC3 gene in human normal pancreas and pancreatic adenocarcinoma tissues. Methods The expression of TUSC3 gene in 20 cases of pancreatic cancer and 6 cases of normal pancreas were detected by oligonucleotide microarray and real-time quantitative PCR. Total RNA were extracted from each sample with TRIzol method. To assure the quality of obtained total RNA, three different examinations were performed which included spectrophotometer, agarose gel electrophoresis and Lab on chip examination. The results of mieroarray hybridization were analysised with Ratio value and verified by realtime quantitative PCR. The product of real-time quantitative PCR was quantitated by comparative Ct method. Results The scanning signal of microarray hybridization was clear, and the aquired images had a lower background and higher signal-noise ratio. The expression of TUSC3 gene in pancreatic adenocarcinoma against normal pancreas was down-regulated ( Cy3/Cy5 〈 0. 5 ) by Ratio analysis, which the average value of Ratio was 0. 297 ± 0. 38. The average quantity of TUSC3 gene in pancreatic adenocarcinoma and normal pancreas detected by QRT-PCR were 0. 0206028 ± 0. 00401 and 0. 0387493 ± 0. 00965 respectively. In comparison with normal pancreas, the expression of TUSC3 gene in pancreatic adenocarcinoma was down-expressed as 1.88 folds ( P 〈 0. 05 ). Conclusion TUSC3 gene was significantly down-expressed in pancreatic adenocarcinoma and its mechanism might be related with age-related hypermethylation in promoter region. However, the real role of TUSC3 gene in pancreatic adenocarcinoma developing has to be evaluated in the future.
作者 卫文俊
出处 《肝胆外科杂志》 2008年第6期463-465,共3页 Journal of Hepatobiliary Surgery
关键词 胰腺癌 TUSC3基因 寡核苷酸基因芯片 pancreatic cancer TUSC3 gene oligonucleotide microarray
  • 相关文献

参考文献7

  • 1Bookstein R, Bova GS, MacGrogan D, et al. Tumour-suppressor genes in prostatic oncogenesis : a positional approach [ J ]. Br J Urol, 1997, 79:8-36.
  • 2Zemliakova VV, Zhevlova AI, Strel'nikov VV, et al. Abnormal methylation of several tumor suppressor genes in sporadic breast cancer [ J ]. Mol Biol( Mosk), 2003, 37 : 696 - 703.
  • 3Ahuja N, Li Q, Mohan AL, et al. Aging and DNA methylation in colorectal mucosa and cancer[ J]. Cancer Res, 1998, 58:5489 - 5494.
  • 4Li Q, Jedlicka A, Ahuja N, et al. Concordant methylation of the ER and N33 genes in glioblastoma muhiforme [ J ]. Oncogene, 1998, 16:3197-3202.
  • 5董明,董雨亭.胰腺癌发病危险因素的研究现状[J].中华普通外科杂志,2003,18(6):382-383. 被引量:5
  • 6Dong M, Nio Y, Sato Y, et al. Comparative study of P53 expression in primary invasive ductal carcinoma of the pancreas between Chinese and Japanese[J]. Pancreas, 1998, 17:229 -237.
  • 7Ahuja N, Issa JP. Aging, methylation and cancer[ J]. Histol Histopathol, 2000, 15 : 835 -842.

二级参考文献16

  • 1Simon B, Printz H. Epidemiological trends in pancreatic neoplasia.Dig Dis,2001,19 : 6-14.
  • 2Rosenberg L. Pancreatic cancer: a review of emerging therapies.Drugs,2000,59 : 1071-1089.
  • 3Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer,1999,80: 827-841.
  • 4Tersmette AC, Petersen GM, Offerhaus GJ, et al. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res.2001.7: 738-744.
  • 5Fisher W. Diabetes: risk factor for the development of pancreatic cancer or manifestation of the disease? World J Surg,2001,25:503-508.
  • 6Silverman DT, Schiffman M, Everhart J, et al. Diabetes mellitus,other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer. 1999.80 : 1830-1837.
  • 7Guo YS, Townsend CM. Roles of gastrointestinal hormones in pancreatic cancer. J Hepatobiliary Pancreat Surg,2000.7: 276-285.
  • 8Alguacil J, Porta M, Malats N, et al. Occupational exposure, to organic solvents and Ki-ras mutations in exocrine pancreatic cancer.Carcinogensis ,2002,23 : 101-106.
  • 9Schenk M, Schwartz AG, O' Neal E, et al. Familial risk of pancreatic cancer. J Natl Cancer Inst,2001, 93 : 640-644.
  • 10Dang M, Nio Y, Sato Y, et al. Comparative study of p53 expression in primary invasive ductal carcinoma of the pancreas between Chinese and Japanese. Pancreas, 1998,17 : 229-237.

共引文献4

同被引文献1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部